<DOC>
	<DOCNO>NCT02860104</DOCNO>
	<brief_summary>The investigator perform study prospectively analyse clinical outcome percutaneous microwave ablation ( MWA ) benign malignant breast lesion ultrasound ( US ) guidance .</brief_summary>
	<brief_title>Ultrasound Guided Percutaneous Microwave Ablation Breast Lesions</brief_title>
	<detailed_description>A total 500 patient diagnosed benign breast lesion 50 patient malignant breast lesion seven center China recruit study underwent US-guided percutaneous MWA treatment . Information patient include demographic ; long diameter tumor ; tumor number ; tumor pathological type ; location tumor accord whether adjacent skin , pectoralis , areola papilla . Ablation variables include session , puncture , time , power ; complete ablation , complication ; reduction volume , palpability , pain cosmetic satisfying outcome , recurrence , survival measure analyze .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>breast lesion prove use coreneedle biopsy ; benign lesion , lesion 1.0 cm large great diameter continually increase half year followup ; malignant one , lesion size 2cm small ; distance least 1.0cm papilla patient supine ; symptom local pain , discomfortable compression consider probably relate lesion breast ; patient evidently psychological pressure due occurrence lesion ; patient unwilling refuse receive treatment presence appropriate route percutaneous puncture US guidance . patient pregnant breastfeeding ; patient evidence coagulopathy acute severe pulmonary insufficiency heart dysfunction ; patient menstrual period ; patient want undergo therapy include surgical excision vacuumassisted biopsy .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>microwave ablation</keyword>
	<keyword>breast</keyword>
	<keyword>multicenter</keyword>
</DOC>